512 related articles for article (PubMed ID: 19996343)
1. Effects of steroid therapy on inflammatory cell subtypes in asthma.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 May; 65(5):384-90. PubMed ID: 19996343
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory subtypes in asthma are related to airway hyperresponsiveness to mannitol and exhaled NO.
Porsbjerg C; Lund TK; Pedersen L; Backer V
J Asthma; 2009 Aug; 46(6):606-12. PubMed ID: 19657904
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory phenotypes in adult asthma: clinical applications.
Gibson PG
Clin Respir J; 2009 Oct; 3(4):198-206. PubMed ID: 20298405
[TBL] [Abstract][Full Text] [Related]
4. Exhaled nitric oxide and exhaled breath condensate pH as predictors of sputum cell counts in optimally treated asthmatic smokers.
Hillas G; Kostikas K; Mantzouranis K; Bessa V; Kontogianni K; Papadaki G; Papiris S; Alchanatis M; Loukides S; Bakakos P
Respirology; 2011 Jul; 16(5):811-8. PubMed ID: 21545371
[TBL] [Abstract][Full Text] [Related]
5. The effect of airway remodelling on airway hyper-responsiveness in asthma.
Kermode JA; Brown NJ; Hardaker KM; Farah CS; Berend N; King GG; Salome CM
Respir Med; 2011 Dec; 105(12):1798-804. PubMed ID: 21820298
[TBL] [Abstract][Full Text] [Related]
6. Effects of treatment changes on asthma phenotype prevalence and airway neutrophil function.
Brooks CR; Van Dalen CJ; Harding E; Hermans IF; Douwes J
BMC Pulm Med; 2017 Dec; 17(1):169. PubMed ID: 29202821
[TBL] [Abstract][Full Text] [Related]
7. Airway cell and cytokine changes in early asthma deterioration after inhaled corticosteroid reduction.
Khor YH; Feltis BN; Reid DW; Ward C; Johns DP; Wood-Baker R; Walters EH
Clin Exp Allergy; 2007 Aug; 37(8):1189-98. PubMed ID: 17651149
[TBL] [Abstract][Full Text] [Related]
8. Can we predict sputum eosinophilia from clinical assessment in patients referred to an adult asthma clinic?
Yap E; Chua WM; Jayaram L; Zeng I; Vandal AC; Garrett J
Intern Med J; 2013 Jan; 43(1):46-52. PubMed ID: 21790924
[TBL] [Abstract][Full Text] [Related]
9. Association between asthma control and bronchial hyperresponsiveness and airways inflammation: a cross-sectional study in daily practice.
Quaedvlieg V; Sele J; Henket M; Louis R
Clin Exp Allergy; 2009 Dec; 39(12):1822-9. PubMed ID: 19817755
[TBL] [Abstract][Full Text] [Related]
10. Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
Basyigit I; Yildiz F; Ozkara SK; Boyaci H; Ilgazli A
Mediators Inflamm; 2004 Aug; 13(4):285-91. PubMed ID: 15545060
[TBL] [Abstract][Full Text] [Related]
11. Time-dependent effects of inhaled corticosteroids on lung function, bronchial hyperresponsiveness, and airway inflammation in asthma.
Mehta V; Stokes JR; Berro A; Romero FA; Casale TB
Ann Allergy Asthma Immunol; 2009 Jul; 103(1):31-7. PubMed ID: 19663124
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhaled versus systemic corticosteroids on exhaled nitric oxide in severe acute asthma.
Khoo SM; Lim TK
Respir Med; 2009 Apr; 103(4):614-20. PubMed ID: 19022641
[TBL] [Abstract][Full Text] [Related]
13. Predictors for failed dose reduction of inhaled corticosteroids in childhood asthma.
Li AM; Tsang TW; Lam HS; Sung RY; Chang AB
Respirology; 2008 May; 13(3):400-7. PubMed ID: 18399863
[TBL] [Abstract][Full Text] [Related]
14. Sputum inflammatory phenotypes are not stable in children with asthma.
Fleming L; Tsartsali L; Wilson N; Regamey N; Bush A
Thorax; 2012 Aug; 67(8):675-81. PubMed ID: 22379070
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of eosinophilic and non-eosinophilic asthma during treatment with inhaled corticosteroids.
Furukawa T; Sakagami T; Koya T; Hasegawa T; Kawakami H; Kimura Y; Hoshino Y; Sakamoto H; Shima K; Tsukioka K; Toyama M; Hayashi M; Kagamu H; Suzuki E; Narita I
J Asthma; 2015 May; 52(4):417-22. PubMed ID: 25329682
[TBL] [Abstract][Full Text] [Related]
16. Lung function and sputum characteristics of patients with severe asthma during an induced exacerbation by double-blind steroid withdrawal.
in't Veen JC; Smits HH; Hiemstra PS; Zwinderman AE; Sterk PJ; Bel EH
Am J Respir Crit Care Med; 1999 Jul; 160(1):93-9. PubMed ID: 10390385
[TBL] [Abstract][Full Text] [Related]
17. Eosinophilic airway inflammation and the prognosis of childhood asthma.
Lovett CJ; Whitehead BF; Gibson PG
Clin Exp Allergy; 2007 Nov; 37(11):1594-601. PubMed ID: 17949371
[TBL] [Abstract][Full Text] [Related]
18. Blunting airway eosinophilic inflammation results in a decreased airway neutrophil response to inhaled LPS in patients with atopic asthma: a role for CD14.
Alexis NE; Peden DB
J Allergy Clin Immunol; 2001 Oct; 108(4):577-80. PubMed ID: 11590384
[TBL] [Abstract][Full Text] [Related]
19. Simvastatin in the treatment of asthma: lack of steroid-sparing effect.
Cowan DC; Cowan JO; Palmay R; Williamson A; Taylor DR
Thorax; 2010 Oct; 65(10):891-6. PubMed ID: 20861293
[TBL] [Abstract][Full Text] [Related]
20. Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids.
Deykin A; Lazarus SC; Fahy JV; Wechsler ME; Boushey HA; Chinchilli VM; Craig TJ; Dimango E; Kraft M; Leone F; Lemanske RF; Martin RJ; Pesola GR; Peters SP; Sorkness CA; Szefler SJ; Israel E;
J Allergy Clin Immunol; 2005 Apr; 115(4):720-7. PubMed ID: 15805990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
